Loading…
Loading…
EKSO (Ekso Bionics Holdings, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
ChronoScale Corporation Common Stock (NASDAQ: CHRN - Get Free Report)'s stock price crossed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $20.32 and traded as high as $22.20. ChronoScale Corporation Common Stock shares last traded at $20.26, with a volume of 233,404 shares trading hands. ChronoScale
DALLAS, May 06, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, today announced the appointment of Cenly Chen as Chief Executive Officer and a member of the Company's Board of Directors.
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO - Get Free Report) major shareholder Daniel Asher bought 15,540 shares of the company's stock in a transaction dated Thursday, February 19th. The shares were purchased at an average price of $12.30 per share, with a total value of $191,142.00. Following the transaction, the insider owned 270,432 shares of the
SAN RAFAEL, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that on January 20, 2026 it entered into securities purchase agreements with certain institutional and accredited investors for the purchase and sale of an aggregate of 5,852 shares of the Company's Series B Preferred Stock (the “Preferred Stock”) and warrants (the “Warrants”) to purchase up to an aggregate of 355,960 shares of common stock of the Company in a private placement transaction (the “Private Placement”).
Applied Digital (APLD) shares surged about 10% on Thursday morning after the company reported fiscal second-quarter revenue of $126.6 million for the period end
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: EKSO Bionics Holdings, Inc.
NEW YORK, Jan. 5, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating EKSO Bionics Holdings, Inc. (NASDAQ: EKSO ) related to its merge with Applied Digital Cloud.
Consumer tech news roundup covering AI investments, semiconductor tensions, EV delivery updates, Big Tech strategy shifts, and policy developments shaping global technology markets.